Growth-oriented investor and operating executive with experience advising and scaling healthcare and technology companies, focused on revenue growth, commercial strategy and board-level governance. Erin Colleen Ross brings cross-functional operating leadership, capital-raising experience and strategic M&A involvement to portfolio companies, often partnering with PE and venture investors to drive exits. Prior roles span corporate development, product-led commercialization and investor relations; education and early career combine business and sector-specific expertise. Market-facing profile emphasizes operational value creation, board oversight and transaction execution for growth-stage businesses.
Growth-oriented investor and operating executive with experience advising and scaling healthcare and technology companies, focused on revenue growth, commercial strategy and board-level governance. Erin Colleen Ross brings cross-functional operating leadership, capital-raising experience and strategic M&A involvement to portfolio companies, often partnering with PE and venture investors to drive exits. Prior roles span corporate development, product-led commercialization and investor relations; education and early career combine business and sector-specific expertise. Market-facing profile emphasizes operational value creation, board oversight and transaction execution for growth-stage businesses.
Growth-stage, operations-first investor prioritizing revenue acceleration and commercial scale; targets healthcare and tech businesses where product-market fit can be amplified through go-to-market, pricing, and strategic partnerships. Capital allocation favors minority growth equity and board-active positions alongside PE/VC sponsors, emphasizing short-to-medium horizons to exit via strategic sale or recap. Underwriting blends commercial metrics, governance readiness and M&A optionality; risk managed via staged capital, KPI-driven milestones and operator-led value creation.
Growth-stage, operations-first investor prioritizing revenue acceleration and commercial scale; targets healthcare and tech businesses where product-market fit can be amplified through go-to-market, pricing, and strategic partnerships. Capital allocation favors minority growth equity and board-active positions alongside PE/VC sponsors, emphasizing short-to-medium horizons to exit via strategic sale or recap. Underwriting blends commercial metrics, governance readiness and M&A optionality; risk managed via staged capital, KPI-driven milestones and operator-led value creation.
| Trades 137 | Longs Won 75/137 54% | Profit Factor 104.65 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $311.41M |
| Average Win $49.67M | Best Trade (Mar 30) $3.65B | Sharpe Ratio -4.54 |
| Average Loss -$574,213.32 | Worst Trade (Mar 30) -$7.51M | Z-Score 1.84 (93.39%) |
| Commissions $0 | Avg. Trade Length 7m 5d | Expectancy $26.97M |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | 55.95% | 66.64% | 73.81% | 79.37% | 83.96% | 87.91% | 91.4% | 94.53% | 97.38% |
| Consecutive Losing Trades | 1,092 | 983 | 873 | 764 | 655 | 546 | 437 | 328 | 218 | 109 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 3,000 | $868,080 | $1.03M | - | $160,380 | 18.48% | +0.24% |
ACWI iShares MSCI ACWI ETF | 385,076 | $49.54M | $60.73M | - | $11.19M | 22.59% | -0.948% |
AES AES Corporation | 1.23M | $17.98M | $18.33M | - | $343,467.01 | 1.91% | -0.2% |
AMZN Amazon.com Inc | 9,500 | $2.08M | $2.37M | - | $284,810 | 13.67% | -2.116% |
AXP American Express Company | 2,000 | $640,730 | $627,140 | - | -$13,590 | -2.12% | -0.096% |
BBJP JPMorgan BetaBuilders Japan Fund | 60,343 | $3.42M | $4.62M | - | $1.2M | 35.14% | -0.519% |
BLD TopBuild Corp | 37,136 | $15.22M | $13.17M | - | -$2.05M | -13.5% | -1.454% |
BRK-B Berkshire Hathaway Inc. | 15,000 | $6.9M | $7.94M | - | $1.05M | 15.2% | +0.742% |
COF Capital One Financial Corporation | 3,833 | $815,509.06 | $771,659.56 | - | -$43,849.5 | -5.38% | +1.237% |
D Dominion Energy, Inc. | 150,000 | $10.24M | $9.54M | - | -$708,000 | -6.91% | +1.129% |
EA Electronic Arts Inc. | 39,412 | $8.08M | $8.26M | - | $183,660.4 | 2.27% | 0.0 |
EWJ iShares MSCI Japan ETF | 4,000 | $268,400 | $379,280 | - | $110,880 | 41.31% | -0.639% |
FLL Full House Resorts Inc. | 61,375 | $147,856 | $66,285 | - | -$81,571 | -55.17% | 0.0 |
GS The Goldman Sachs Group, Inc. | 1,000 | $845,990 | $879,870 | - | $33,880 | 4% | -1.28% |
GTLS Chart Industries Inc. | 285,399 | $58.41M | $59.91M | - | $1.49M | 2.55% | -0.005% |
IEUR iShares Core MSCI Europe ETF | 55,000 | $2.97M | $4.07M | - | $1.1M | 37.18% | 0.0 |
IVE ISHARES S&P 500 VALUE ETF | 5,000 | $954,400 | $1.18M | - | $221,750 | 23.23% | -0.182% |
JPM JPMorgan Chase & Co. | 2,000 | $588,320 | $677,280 | - | $88,960 | 15.12% | +0.927% |
KVUE Kenvue Inc. | 3.01M | $54.78M | $56.49M | - | $1.71M | 3.12% | +0.696% |
MS Morgan Stanley | 4,000 | $658,280 | $722,640 | - | $64,360 | 9.78% | -0.791% |